Pompermayer, Kenia <br/><br/>
Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury.  [electronic resource] 

 -  European journal of pharmacology  Feb 2007 
 - 215-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2999 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2006.10.065  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--physiology<br/>Animals<br/>Capillary Permeability--drug effects<br/>Chemotaxis, Leukocyte--drug effects<br/>Cytokines--biosynthesis<br/>Glyburide--administration & dosage<br/>Intestines--blood supply<br/>Ion Channel Gating<br/>Ischemia--pathology<br/>Male<br/>Mesenteric Artery, Superior--physiopathology<br/>Minoxidil--therapeutic use<br/>Neutrophils--drug effects<br/>Potassium Channel Blockers--administration & dosage<br/>Rats<br/>Rats, Wistar<br/>Reperfusion Injury--mortality<br/>Tetraethylammonium--therapeutic use